EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Transformative trials in cesarean delivery: Antibiotic prophylaxis, tranexamic acid, and uterine closure

Ellen M Murrin, Scott A Sullivan, George Larry Maxwell, Antonio F Saad

Seminars in Perinatology · 2025

DOI: 10.1016/j.semperi.2025.152145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Perinatology, 2025. Verfasst von Ellen M Murrin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal Fetal Medicine, Inova Fairfax Medical Campus, 3300 Gallows RD, Falls Church, VA 22032, United States. Electronic address: Elle…. Hauptthemen laut MEDLINE: Tranexamic Acid, Antibiotic Prophylaxis, Cesarean Section, Postpartum Hemorrhage. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cesarean delivery (CD), performed in nearly one in three U.S. births, is the most common surgical procedure. As utilization has increased, advances in surgical technique and perioperative management, guided by landmark trials, have refined the procedure and improved outcomes. Some of the most significant trials have focused on antibiotic prophylaxis, prevention of postpartum hemorrhage, and standardization of surgical techniques. For example, pre-incision prophylactic cefazolin has reduced the risk of postoperative infectious morbidity up to 60% compared to administration at the time of cord clamping. Additionally, the introduction of TXA to the treatment of obstetric hemorrhage has been shown to reduce maternal mortality related to hemorrhage. Future research should prioritize continuing reduction of maternal morbidity as CD still incurs increased risk of infectious and bleeding morbidity. Another important focus in the era of increased CD rates is research into the optimal closure of the hysterotomy. Identification of patients at risk of uterine rupture in future pregnancies can improve the safety of trial of labor after cesarean delivery (TOLAC); further investigation into how hysterotomy closure may contribute to the development of placenta accreta spectrum can significantly decrease maternal morbidity from an increasingly common and life-threatening placental disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidAntibiotic ProphylaxisCesarean SectionPostpartum HemorrhageAntifibrinolytic AgentsHumansFemalePregnancyHysterotomySurgical Wound InfectionCefazolinAnti-Bacterial Agents

Stichwörter der Autor:innen

Cesarean deliveryEvidence-basedMaternal infectionMaternal morbidityTranexamic acidantibiotics

Substanzen

Tranexamic AcidAntifibrinolytic AgentsCefazolinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Maternal Fetal Medicine, Inova Fairfax Medical Campus, 3300 Gallows RD, Falls Church, VA 22032, United States. Electronic address: Ellen.Murrin@inova.org.
  • Department of Maternal Fetal Medicine, Inova Fairfax Medical Campus, 3300 Gallows RD, Falls Church, VA 22032, United States.
  • Department of Maternal Fetal Medicine, Inova Fairfax Medical Campus, 3300 Gallows RD, Falls Church, VA 22032, United States. Electronic address: antonio.saad@inova.org.

Zitieren

APA

Murrin, E. M., Sullivan, S. A., Maxwell, G. L., & Saad, A. F. (2025). Transformative trials in cesarean delivery: Antibiotic prophylaxis, tranexamic acid, and uterine closure. Seminars in Perinatology. https://doi.org/10.1016/j.semperi.2025.152145

Vancouver

Murrin EM, Sullivan SA, Maxwell GL, Saad AF. Transformative trials in cesarean delivery: Antibiotic prophylaxis, tranexamic acid, and uterine closure. Seminars in Perinatology. 2025. doi:10.1016/j.semperi.2025.152145

BibTeX
@article{Murrin2025,
  author = {Murrin, Ellen M and Sullivan, Scott A and Maxwell, George Larry and Saad, Antonio F},
  title = {Transformative trials in cesarean delivery: Antibiotic prophylaxis, tranexamic acid, and uterine closure},
  journal = {Seminars in Perinatology},
  year = {2025},
  doi = {10.1016/j.semperi.2025.152145}
}
Kostenlos starten →